Ce graphe indique pour toute la population étudiée le délais avant traitement.
Après 3 ans, 4 sur 10 ont été traités
TFS = treatment free survival = délais avant traitement
WBC = white blood cell = leucocytes
From November 2002 to December 2008, 112 young patients (<65 years) diagnosed with CLL at our institution were included in the study. There were 62 males and 50 females, with a median age of 52 years (range 29-68). Eighty-one percent were in Binet stage A, 19% were in stages B/C.
extrait de
White blood cell count at diagnosis and immunoglobulin variable region gene
mutations are independent predictors of treatment-free survival
in young patients with stage A chronic lymphocytic leukemia
Ilaria Del Giudice,1 Francesca Romana Mauro,1 Maria Stefania De Propris,1 Simona Santangelo,1 Marilisa Marinelli,1
Nadia Peragine,1 Valeria Di Maio,1 Mauro Nanni,1 Rita Barzotti,1 Francesca Mancini,1 Daniele Armiento,1
Francesca Paoloni,2 Anna Guarini,1 and Robin Foà1
Obtained from Haematologica/the Hematology Journal website http://www.haematologica.org
Libellés
LLC
(100)
LLC 11q-
(2)
LLC anticorp monoclonal
(4)
LLC avis sur les traitements
(2)
LLC consultation mon cas
(11)
LLC Définition
(2)
LLC Dr Terry Hamblin
(13)
LLC éléments analysés
(5)
LLC Essais Cliniques
(11)
LLC étude d'un point
(4)
LLC exemple de traitement
(1)
LLC Genetique
(2)
LLC groupe de patients
(1)
LLC immunodepression
(1)
LLC les bases
(1)
LLC Mes Analyses
(6)
LLC molecule
(16)
LLC Molecule Arzerra
(1)
LLC Molecule Cirmtuzumab
(1)
LLC Molecule Gaziva
(1)
LLC molecule Ibrutinib
(3)
LLC molecule idelalisib
(2)
LLC MonTraitement1
(9)
LLC revue du net
(1)
LLC statistique survie
(8)
LLC témoignage après chimio
(1)
LLC témoignage chimio
(4)
LLC TH But du traitement
(1)
LLC TH Conseils
(1)
LLC TH CT scan
(1)
LLC TH Etudes
(1)
LLC TH Greffe
(1)
LLC TH Immunodeficience
(2)
LLC TH Les Traitements
(1)
LLC TH MBR
(1)
LLC TH Molecules
(1)
LLC TH Pronostiqueurs
(1)
LLC Traitement
(10)
LLC video
(1)
Traitement
(1)
Inscription à :
Publier les commentaires (Atom)

Aucun commentaire:
Enregistrer un commentaire